Free Trial

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Consensus Recommendation of "Hold" from Analysts

DENTSPLY SIRONA logo with Medical background

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Free Report) has earned an average recommendation of "Hold" from the fourteen brokerages that are presently covering the company, MarketBeat.com reports. Twelve investment analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 12 month price target among brokerages that have covered the stock in the last year is $22.58.

Several equities research analysts recently issued reports on XRAY shares. Mizuho dropped their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a research note on Thursday, March 13th. Robert W. Baird reduced their target price on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a research note on Friday, February 28th. Evercore ISI reaffirmed an "in-line" rating and set a $20.00 price target on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Needham & Company LLC reiterated a "hold" rating on shares of DENTSPLY SIRONA in a research report on Thursday, March 13th. Finally, Jefferies Financial Group downgraded DENTSPLY SIRONA from a "buy" rating to a "hold" rating and decreased their price objective for the stock from $30.00 to $20.00 in a report on Thursday, January 23rd.

View Our Latest Analysis on XRAY

Insider Buying and Selling

In related news, Director Gregory T. Lucier purchased 15,142 shares of DENTSPLY SIRONA stock in a transaction that occurred on Monday, March 3rd. The shares were bought at an average price of $16.51 per share, with a total value of $249,994.42. Following the purchase, the director now directly owns 81,971 shares of the company's stock, valued at approximately $1,353,341.21. This represents a 22.66 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.52% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On DENTSPLY SIRONA

Institutional investors have recently added to or reduced their stakes in the stock. Nordea Investment Management AB increased its position in shares of DENTSPLY SIRONA by 245.0% in the 4th quarter. Nordea Investment Management AB now owns 251,556 shares of the medical instruments supplier's stock valued at $4,754,000 after acquiring an additional 178,639 shares during the period. JPMorgan Chase & Co. boosted its position in DENTSPLY SIRONA by 206.3% during the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier's stock worth $49,990,000 after purchasing an additional 1,244,326 shares in the last quarter. Bank of New York Mellon Corp raised its position in DENTSPLY SIRONA by 27.9% during the fourth quarter. Bank of New York Mellon Corp now owns 2,403,110 shares of the medical instruments supplier's stock worth $45,611,000 after acquiring an additional 523,692 shares during the period. Charles Schwab Investment Management Inc. increased its stake in DENTSPLY SIRONA by 1.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,101,133 shares of the medical instruments supplier's stock worth $39,880,000 after buying an additional 35,360 shares in the last quarter. Finally, Barclays PLC raised its stake in DENTSPLY SIRONA by 21.8% in the 3rd quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier's stock valued at $8,301,000 after purchasing an additional 54,920 shares during the last quarter. Institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ XRAY opened at $12.83 on Friday. The stock has a fifty day simple moving average of $15.61 and a two-hundred day simple moving average of $18.69. The firm has a market cap of $2.56 billion, a price-to-earnings ratio of -6.20, a price-to-earnings-growth ratio of 1.80 and a beta of 0.92. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA has a 1-year low of $12.16 and a 1-year high of $31.00.

DENTSPLY SIRONA Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 4.99%. The ex-dividend date was Friday, March 28th. DENTSPLY SIRONA's dividend payout ratio (DPR) is currently -14.07%.

About DENTSPLY SIRONA

(Get Free Report

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Featured Articles

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in DENTSPLY SIRONA Right Now?

Before you consider DENTSPLY SIRONA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.

While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market
Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines